Subscribe To
CYBN / Cybin, Deepak Chopra Announce Partnership For Psychedelics Awareness And Education
Content Topics
Banner
Acquisition
Corp
Bnnru
Cybin
Deepak
Chopra
Announce
Partnership
Psychedelics
Awareness
Education
Stock
CYBN
CYBN News
By Business Wire
September 25, 2023
Cybin to Participate in the Cantor Global Healthcare Conference
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company co more_horizontal
By Business Wire
September 21, 2023
Cybin Announces Date of Annual and Special Meeting of Shareholders
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company co more_horizontal
By Proactive Investors
September 20, 2023
Cybin shares continue to rise on major investment from Steve Cohen's hedge fund
Cybin Inc. (NYSE-A:CYBN, NEO:CYBN) shares maintained upward momentum on Wednesday after soaring earlier this week on the news New York Mets owner Stev more_horizontal
By Market Watch
September 18, 2023
Psychedelic stock jumps as Steve Cohen's Point72 snaps up shares
Shares of Cybin Inc., CYBN, +39.39% a developer of psychedelic therapies, finished 38.5% higher on Monday after billionaire investor and New York Mets more_horizontal
By InvestorPlace
September 14, 2023
The 3 Most Undervalued Under-$1 Stocks to Buy in September 2023
The global inflation surge and monetary policy tightening by major central banks have all contributed to the market volatility this year. Despite that more_horizontal
By Proactive Investors
June 29, 2023
Cybin narrows net loss year-over-year; eyes FDA submission in late 2023
Cybin Inc. (NYSE-A:CYBN, NEO:CYBN) reported that it has narrowed its net loss year-over-year as it has advanced its two lead clinical programs CYB003 more_horizontal
By PennyStocks
June 15, 2023
Best Penny Stocks to Buy Under $1? 4 To Watch Now
Ever find yourself daydreaming about striking it rich in the stock market? Well, buckle up, because we're about to dive headfirst into the world of pe more_horizontal
By Proactive Investors
February 15, 2023
Cybin shares rise as 3Q results meet expectations, analysts maintain ‘positive bias outlook'
Cybin Inc. (NYSE-A:CYBN, NEO:CYBN) shares moved higher just after the market opened on Wednesday after the psychedelics-focused biopharmaceutical c more_horizontal